Pastorino U - Search Results

1

Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation.

Sands J, Tammemägi MC, Couraud S, Baldwin DR, Borondy-Kitts A, Yankelevitz D, Lewis J, Grannis F, Kauczor HU, von Stackelberg O, Sequist L, Pastorino U, McKee B. Sands J, et al. Among authors: pastorino u. J Thorac Oncol. 2021 Jan;16(1):37-53. doi: 10.1016/j.jtho.2020.10.127. Epub 2020 Nov 12. J Thorac Oncol. 2021. PMID: 33188913 Free article. Review.

2

Early detection of lung cancer.

Pastorino U. Pastorino U. Respiration. 2006;73(1):5-13. doi: 10.1159/000090990. Respiration. 2006. PMID: 16498267 Review.

3

Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.

Pastorino U, Calabrò E, Tamborini E, Marchianò A, Orsenigo M, Fabbri A, Sozzi G, Novello S, De Marinis F. Pastorino U, et al. J Thorac Oncol. 2009 Feb;4(2):266-7. doi: 10.1097/JTO.0b013e3181952930. J Thorac Oncol. 2009. PMID: 19179908 Free article.

4

Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.

Pastorino U, Landoni C, Marchianò A, Calabrò E, Sozzi G, Miceli R, Picchio M, Mariani L, Messa C, Fazio F. Pastorino U, et al. J Thorac Oncol. 2009 Nov;4(11):1352-6. doi: 10.1097/JTO.0b013e3181bbf1dc. J Thorac Oncol. 2009. PMID: 19861905 Free article.

5

The development of an international registry.

Pastorino U. Pastorino U. J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S196-7. doi: 10.1097/JTO.0b013e3181dcf987. J Thorac Oncol. 2010. PMID: 20502262 Free article. No abstract available.

6

Defining the intra-subject variability of whole-lung CT densitometry in two lung cancer screening trials.

Diciotti S, Sverzellati N, Kauczor HU, Lombardo S, Falchini M, Favilli G, Macconi L, Kuhnigk JM, Marchianò A, Pastorino U, Zompatori M, Mascalchi M. Diciotti S, et al. Among authors: pastorino u. Acad Radiol. 2011 Nov;18(11):1403-11. doi: 10.1016/j.acra.2011.08.001. Acad Radiol. 2011. PMID: 21971258

7

Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.

Andriani F, Roz E, Caserini R, Conte D, Pastorino U, Sozzi G, Roz L. Andriani F, et al. Among authors: pastorino u. J Thorac Oncol. 2012 Apr;7(4):631-42. doi: 10.1097/JTO.0b013e318244aed0. J Thorac Oncol. 2012. PMID: 22425911 Free article.

8

Long-term surveillance of ground-glass nodules: evidence from the MILD trial.

Silva M, Sverzellati N, Manna C, Negrini G, Marchianò A, Zompatori M, Rossi C, Pastorino U. Silva M, et al. Among authors: pastorino u. J Thorac Oncol. 2012 Oct;7(10):1541-6. doi: 10.1097/JTO.0b013e3182641bba. J Thorac Oncol. 2012. PMID: 22968185 Free article. Clinical Trial.

9

Current status of lung cancer screening.

Pastorino U. Pastorino U. Thorac Surg Clin. 2013 May;23(2):129-40. doi: 10.1016/j.thorsurg.2013.01.018. Thorac Surg Clin. 2013. PMID: 23566965 Review.

10

European randomized lung cancer screening trials: Post NLST.

Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M, de Koning HJ; European Randomized Screening Trial Group. Field JK, et al. Among authors: pastorino u. J Surg Oncol. 2013 Oct;108(5):280-6. doi: 10.1002/jso.23383. Epub 2013 Jul 25. J Surg Oncol. 2013. PMID: 23893464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page